What is the appropriate first‑line treatment for hiccups in a patient with acute kidney injury and oxaliplatin‑induced seizures?

Management of Hiccups in a Patient with Acute Kidney Injury and Oxaliplatin-Induced Seizures

In this complex clinical scenario, metoclopramide 10 mg three times daily should be the first-line pharmacologic treatment for persistent hiccups, with careful attention to avoiding nephrotoxic agents and managing the underlying acute kidney injury. 1

Immediate Considerations

Oxaliplatin Discontinuation

• Permanently discontinue oxaliplatin given the patient has experienced seizures, which represents a severe neurologic toxicity requiring immediate cessation of the drug. 2
• Oxaliplatin can cause posterior reversible encephalopathy syndrome (PRES) and other serious neurologic complications that mandate permanent discontinuation. 2

Seizure Management Priority

• The seizure disorder takes precedence over hiccup management in terms of morbidity and mortality risk. 3
• If seizures are refractory to benzodiazepines, second-line agents including fosphenytoin, levetiracetam, or valproate should be administered with similar efficacy. 3
• Levetiracetam may be preferred in this context given the acute kidney injury, as it has the lowest rate of life-threatening hypotension (0.7%) compared to other agents. 3

First-Line Treatment for Hiccups

Metoclopramide as Primary Agent

• Metoclopramide 10 mg three times daily for up to 15 days is supported by the only randomized controlled trial data for intractable hiccups, showing significantly higher total efficacy compared to placebo (relative risk 2.75,95% CI: 1.09-6.94, P = 0.03). 1
• This agent demonstrated efficacy in 59.6% of patients as first-line treatment with only mild adverse events including fatigue, upset mood, and dizziness. 1, 4
• Metoclopramide is particularly relevant as it was the most commonly used first-line agent (96.8%) in patients receiving platinum-based chemotherapy. 4

Dose Adjustment for Renal Impairment

• Critical consideration: Metoclopramide requires dose reduction in severe renal impairment (CrCl <30 mL/min). 5
• Monitor for extrapyramidal symptoms more closely in the setting of renal dysfunction, as drug accumulation increases this risk.

Alternative Pharmacologic Options

Second-Line Agents if Metoclopramide Fails

Baclofen is the strongest alternative option:

• Supported by small randomized placebo-controlled trial data. 6
• May be preferred for long-term therapy due to lower risk of side effects compared to neuroleptic agents. 6
• However, requires significant dose reduction in renal impairment, which is a major limitation in this patient. 6

Gabapentin as another alternative:

• Also supported by randomized trial data and observational studies. 7, 6
• Less likely to cause side effects during long-term therapy compared to neuroleptics. 6
• Requires substantial dose adjustment for renal function - this is critical in acute kidney injury. 7

Chlorpromazine Considerations

• Chlorpromazine is the only FDA-approved drug specifically for hiccups; however, it lacks robust trial data. 7, 6
• Typical dosing is 37.5 mg/day divided three times daily. 8
• Use with extreme caution in this patient given the seizure history, as chlorpromazine lowers seizure threshold and could worsen seizure control.
• May cause significant sedation and hypotension, particularly problematic in acute kidney injury. 6

Critical Pitfalls to Avoid

Nephrotoxin Stewardship

• Avoid any additional nephrotoxic medications in the setting of acute kidney injury, as this directly impacts mortality and progression to chronic kidney disease. 9, 10
• The acute kidney injury itself requires aggressive management to prevent progression and improve outcomes. 9

Drug Dosing Adjustments

• All medications must be dose-adjusted for the degree of renal impairment using validated GFR equations. 5, 10
• Failure to adjust doses increases risk of drug accumulation and toxicity, particularly for renally cleared medications. 10

Seizure Medication Interactions

• Ensure the chosen hiccup treatment does not interact with antiseizure medications or lower seizure threshold. 3
• Avoid chlorpromazine and other neuroleptics if possible given seizure history. 7

Monitoring and Follow-up

• Assess hiccup response within 2-5 days of initiating therapy, as most effective treatments show benefit in this timeframe. 8, 1
• Monitor renal function closely and adjust all medication doses accordingly. 5, 10
• Continue antiseizure therapy as prescribed and monitor for seizure recurrence. 3
• If hiccups persist beyond 5 days despite metoclopramide, consider switching to baclofen or gabapentin with appropriate renal dose adjustment. 6, 1